Investing

Editor's Top Picks

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form Investing

Cargo Therapeutics rises 2.2% in trading debut after IPO priced at low end of range

The stock of Cargo Therapeutics CRGX, -3.13%,  a clinical-stage biotech specializing in cancer treatments, rose

Curaleaf and Canopy Growth miss third-quarter analyst marks while Green Thumb, Ascend Wellness, TerrAscend and Trulieve beat forecasts

Quarterly results from the United States’ largest cannabis company, Curaleaf Holdings Inc., and from Canada’s

Bitcoin could reach $150,000 in 2025 during new bull cycle, says AllianceBernstein

Bitcoin could reach a cycle high of as much as $150,000 in 2025, driven by

Moody’s cuts outlook on U.S. credit rating to negative from stable

Moody’s Investors Service late Friday cut its outlook on the U.S. sovereign credit rating to

Elon Musk biopic in development at A24. Director is ‘one of the best,’ Musk says.

A biopic based on the life of tech billionaire Elon Musk is in development at

How 60/40 Worked The Last Time Rates Were This High

Hedging equity exposure with bond investments did not work out as hoped last year. The

Oil ends higher after 2-day drop to nearly 4-month lows

Oil futures climbed Thursday, shaking off data that pointed to weak Chinese consumer demand to

FirstEnergy’s New Jersey Subsidiary Proposes 5-Year, $935M Improvement Plan

By Ben Glickman FirstEnergy subsidiary Jersey Central Power and Light is proposing a five-year infrastructure

Zeekr Intelligent Technology Holding Files IPO

By Emon Reiser Zeekr Intelligent Technology on Thursday filed for an initial public offering with

Biden-Xi Meeting Confirmed, US Dollar Weighs On Risk Assets, Week In Review

Week in Review Asian equities were mixed this week, which began with gains in Korea

Hilton Worldwide Adds $3 Billion to Buyback Authorization

By Josh Beckerman Hilton Worldwide Holdings authorized the repurchase of an additional $3 billion of

Takeda Gets FDA Approval For Blood-Clotting Disorder Treatment

By Ben Glickman Takeda's treatment for a rare blood clotting disorder received approval from the

Bank of Canada to Monitor Potential Fallout From Mortgage Renewals, No. 2 Official Rogers Says — Update

By Paul Vieira OTTAWA--The Bank of Canada will keep close tabs over the next three

MGM Reaches Deal With Union to Avert a Strike. That’s Not the Only Good News.

MGM Resorts International averted a strike by reaching a tentative deal with the Culinary and

Disney, AMC, Affirm, Arm, Virgin Galactic, Topgolf, TransDigm, and More Market Movers

Stocks sank Thursday, ending winning streaks for the S&P 500 and Nasdaq Composite. These stocks